WEKO3
アイテム
Responses of renal hemodynamics and tubular functions to acute sodium-glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats
https://kagawa-u.repo.nii.ac.jp/records/354
https://kagawa-u.repo.nii.ac.jp/records/354abce704a-bdfd-47c6-9a8d-d3e21717ebb7
名前 / ファイル | ライセンス | アクション |
---|---|---|
本文 (524.8 kB)
|
||
内容の要旨 (103.5 kB)
|
|
|
審査の結果の要旨 (446.9 kB)
|
|
Item type | 学位論文 / Thesis or Dissertation(1) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
公開日 | 2019-04-24 | |||||||||||
タイトル | ||||||||||||
タイトル | Responses of renal hemodynamics and tubular functions to acute sodium-glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats | |||||||||||
言語 | en | |||||||||||
言語 | ||||||||||||
言語 | eng | |||||||||||
資源タイプ | ||||||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_db06 | |||||||||||
資源タイプ | doctoral thesis | |||||||||||
アクセス権 | ||||||||||||
アクセス権 | open access | |||||||||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||||||
著者 |
Ansary, Tuba Musarrat
× Ansary, Tuba Musarrat
WEKO
39
|
|||||||||||
抄録 | ||||||||||||
内容記述タイプ | Abstract | |||||||||||
内容記述 | Abstract The aim of this study is to examine the effects of acute administration of luseogliflozin, the sodium–glucose cotransporter 2 (SGLT2) inhibitor, on renal hemodynamics and tubular functions in anesthetized non-diabetic Sprague Dawley (SD) rats and 5/6 nephrectomized (Nx) SD rats. Renal blood flow (RBF), mean arterial pressure (MAP), and heart rate (HR) were continuously measured and urine was collected directly from the left ureter. Intraperitoneal injection of luseogliflozin (0.9 mg kg−1) did not change MAP, HR, RBF, or creatinine clearance (CrCl) in SD rats (n = 7). Luseogliflozin significantly increased urine volume, which was associated with significantly increased urinary glucose excretion rates (P < 0.001). Similarly, luseogliflozin significantly increased urinary sodium excretion (from 0.07 ± 0.01 µmol min−1 at baseline to 0.76 ± 0.08 µmol min−1 at 120 min; P < 0.001). Furthermore, luseogliflozin resulted in significantly increased urinary pH (P < 0.001) and decreased urinary osmolality and urea concentration (P < 0.001) in SD rats. Similarly, in Nx SD rats (n = 5–6), luseogliflozin significantly increased urine volume and urinary glucose excretion (P < 0.001) without altering MAP, HR, RBF, or CrCl. Luseogliflozin did not elicit any significant effects on the other urinary parameters in Nx SD rats. These data indicate that SGLT2 inhibitor elicits direct tubular effects in non-diabetic rats with normal renal functions. |
|||||||||||
言語 | en | |||||||||||
学位名 | ||||||||||||
言語 | ja | |||||||||||
学位名 | 博士(医学) | |||||||||||
学位授与機関 | ||||||||||||
学位授与機関識別子Scheme | kakenhi | |||||||||||
学位授与機関識別子 | 16201 | |||||||||||
言語 | ja | |||||||||||
学位授与機関名 | 香川大学 | |||||||||||
言語 | en | |||||||||||
学位授与機関名 | Kagawa University | |||||||||||
学位授与年月日 | ||||||||||||
学位授与年月日 | 2019-03-24 | |||||||||||
学位授与番号 | ||||||||||||
学位授与番号 | 甲第710号 | |||||||||||
権利 | ||||||||||||
言語 | en | |||||||||||
権利情報 | Copyright © 2017, The Author(s) | |||||||||||
権利 | ||||||||||||
言語 | en | |||||||||||
権利情報Resource | https://creativecommons.org/licenses/by/4.0/ | |||||||||||
権利情報 | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. | |||||||||||
論文ID(NAID) | ||||||||||||
識別子タイプ | NAID | |||||||||||
関連識別子 | 500001345357 | |||||||||||
PubMed番号 | ||||||||||||
識別子タイプ | PMID | |||||||||||
関連識別子 | 28842583 | |||||||||||
関連サイト | ||||||||||||
関連タイプ | isVersionOf | |||||||||||
識別子タイプ | DOI | |||||||||||
関連識別子 | https://doi.org/10.1038/s41598-017-09352-5 | |||||||||||
関連サイト | ||||||||||||
関連タイプ | isIdenticalTo | |||||||||||
識別子タイプ | URI | |||||||||||
関連識別子 | https://dl.ndl.go.jp/pid/11279132 | |||||||||||
関連サイト | ||||||||||||
関連タイプ | hasVersion | |||||||||||
識別子タイプ | URI | |||||||||||
関連識別子 | http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5572725/ | |||||||||||
著者版フラグ | ||||||||||||
出版タイプ | P | |||||||||||
出版タイプResource | http://purl.org/coar/version/c_fa2ee174bc00049f | |||||||||||
KEID | ||||||||||||
値 | 28673 |